title: Pharmacokinetics of maraviroc, raltegravir, darunavir, and etravirine in the semen of HIV-infected men.
authors: Tony
authors: T
authors: Antoniou
authors: Sumaira
authors: S
authors: Hasan
authors: Mona R
authors: MR
authors: Loutfy
authors: Colin
authors: C
authors: Kovacs
authors: Jason
authors: J
authors: Brunetta
authors: Graham
authors: G
authors: Smith
authors: Roberta
authors: R
authors: Halpenny
authors: Charles
authors: C
authors: La Porte
mesh_terms: D019380:Anti-HIV Agents / Q000493:pharmacokinetics*; D019540:Area Under Curve; D003510:Cyclohexanes / Q000493:pharmacokinetics; D000069454:Darunavir; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D008297:Male; D000077592:Maraviroc; D008875:Middle Aged; D009570:Nitriles; D011446:Prospective Studies; D011724:Pyridazines / Q000493:pharmacokinetics; D011743:Pyrimidines; D011760:Pyrrolidinones / Q000493:pharmacokinetics; D000068898:Raltegravir Potassium; D012661:Semen / Q000378:metabolism*; D013449:Sulfonamides / Q000493:pharmacokinetics; D014230:Triazoles / Q000493:pharmacokinetics
chemical_list: D019380:Anti-HIV Agents; D003510:Cyclohexanes; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D011760:Pyrrolidinones; D013449:Sulfonamides; D014230:Triazoles; C451734:etravirine; D000068898:Raltegravir Potassium; D000077592:Maraviroc; D000069454:Darunavir